Methylmalonic acid in serum from patients with neurological symptoms consistent with cobalamin deficiency
| Autor: | Karl Aage Rasmussen, J. Erik Just Christensen, M. Worm, P. Johannsen, Karen Østergaard |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
medicine.medical_specialty
integumentary system business.industry Methylmalonic acid nutritional and metabolic diseases food and beverages Cobalamin Gastroenterology Nerve conduction velocity chemistry.chemical_compound Endocrinology Neurology chemistry hemic and lymphatic diseases Internal medicine polycyclic compounds Medicine Neurology (clinical) business Prospective cohort study |
| Zdroj: | European journal of neurology. 2(4) |
| ISSN: | 1351-5101 |
| Popis: | Patients may have neurological symptoms due to cobalamin deficiency in spite of a normal plasma cobalamin level. The aim of the present study was to test if serum-methylmalonic acid (S-MMA) can identify these cobalamin deficient patients. Patients with neurological symptoms consistent with cobalamin deficiency and normal plasma cobalamin had an estimation of S-MMA. If S-MMA was elevated, treatment with by droxycobalamin was offered. The patients were followed for one year in a prospective study with blood tests, clinical assessment and neurophysiological tests. Serum-MMA was above 0.37 μmol/l (+2 SD of normal mean) in 15 out of 134 patients (11.2%) tested. Twelve of these patients were treated with hydroxycobalamin injections. A significant decrease in S-MMA below 0.37 μmol/l was found in 11 patients treated, indicating a functional cobalamin deficiency. Five patients were followed for one year. Documented improvement of neurological symptoms and nerve conduction velocity was shown in three of these patients. Of the remaining two patients treated one did not change and one deteriorated. S-MMA can identify patients with neurological symptoms due to cobalamin deficiency in spite of a normal plasma cobalamin level. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text